$14.50-4.73%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Ultragenyx Pharmaceutical last closed at $14.50 (-4.73%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -2.5×. Its overall grade ranks 93 of 741 stocks in Healthcare.
About this company
Ultragenyx Pharmaceutical last closed at $14.50 (-4.73%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A · 93/741
Valuation grade A+
Related stocks
- RocheCompetitor
희귀질환 치료제 분야 글로벌 경쟁사
- BioMarin PharmaceuticalCompetitor
희귀유전질환·효소대체치료제 경쟁사
- Alexion PharmaceuticalsCompetitor
희귀질환 치료제 시장의 핵심 경쟁사
About Ultragenyx Pharmaceutical
- What technical signals does Ultragenyx Pharmaceutical (RARE) have?
- Ultragenyx Pharmaceutical current technical signals: no active technical signal.
- Is Ultragenyx Pharmaceutical a cup-and-handle pattern?
- No. Ultragenyx Pharmaceutical has no valid Cup signal right now.
- What published figures are available for Ultragenyx Pharmaceutical?
- Market cap: $1.4B. Trailing 12 months PER: -2.5×. Latest quarter PBR: -5.20×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Ultragenyx Pharmaceutical, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy